Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free SKYAW Stock Alerts

SkyAI, Inc. Warrant (SKYAW) Competitors

$0.02 0.00 (-8.24%)
As of 07/10/2026 03:39 PM Eastern
Compare

SKYAW vs. SSKN, DYNT, XAGE, BIOL, and PFSA

Should you buy SkyAI, Inc. Warrant stock or one of its competitors? MarketBeat compares SkyAI, Inc. Warrant with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SkyAI, Inc. Warrant include Strata Skin Sciences (SSKN), Dynatronics (DYNT), Longevity Health (XAGE), BIOLASE (BIOL), and Profusa (PFSA). These companies are all part of the "medical equipment" industry.

How does SkyAI, Inc. Warrant compare to Strata Skin Sciences?

SkyAI, Inc. Warrant (NASDAQ:SKYAW) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SkyAI, Inc. Warrant
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

SkyAI, Inc. Warrant has higher earnings, but lower revenue than Strata Skin Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SkyAI, Inc. Warrant$396.90K0.54N/AN/AN/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. SkyAI, Inc. Warrant's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SkyAI, Inc. WarrantN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, SkyAI, Inc. Warrant had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 1 mentions for SkyAI, Inc. Warrant and 0 mentions for Strata Skin Sciences. SkyAI, Inc. Warrant's average media sentiment score of 1.87 beat Strata Skin Sciences' score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the media.

Company Overall Sentiment
SkyAI, Inc. Warrant Very Positive
Strata Skin Sciences Neutral

Summary

SkyAI, Inc. Warrant beats Strata Skin Sciences on 6 of the 10 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to Dynatronics?

SkyAI, Inc. Warrant (NASDAQ:SKYAW) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. SkyAI, Inc. Warrant's return on equity of 0.00% beat Dynatronics' return on equity.

Company Net Margins Return on Equity Return on Assets
SkyAI, Inc. WarrantN/A N/A N/A
Dynatronics -8.35%-41.81%-9.56%

In the previous week, SkyAI, Inc. Warrant had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for SkyAI, Inc. Warrant and 0 mentions for Dynatronics. SkyAI, Inc. Warrant's average media sentiment score of 1.87 beat Dynatronics' score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the media.

Company Overall Sentiment
SkyAI, Inc. Warrant Very Positive
Dynatronics Neutral

SkyAI, Inc. Warrant has higher earnings, but lower revenue than Dynatronics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SkyAI, Inc. Warrant$396.90K0.54N/AN/AN/A
Dynatronics$33.60M0.00-$2.70M-$1.35N/A

4.2% of Dynatronics shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

SkyAI, Inc. Warrant beats Dynatronics on 5 of the 8 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to Longevity Health?

Longevity Health (NASDAQ:XAGE) and SkyAI, Inc. Warrant (NASDAQ:SKYAW) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

SkyAI, Inc. Warrant has lower revenue, but higher earnings than Longevity Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Longevity Health$1.05M0.38-$10.37M-$4.29N/A
SkyAI, Inc. Warrant$396.90K0.54N/AN/AN/A

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%.

Company Net Margins Return on Equity Return on Assets
Longevity Health-682.67% N/A -261.90%
SkyAI, Inc. Warrant N/A N/A N/A

In the previous week, SkyAI, Inc. Warrant had 1 more articles in the media than Longevity Health. MarketBeat recorded 1 mentions for SkyAI, Inc. Warrant and 0 mentions for Longevity Health. SkyAI, Inc. Warrant's average media sentiment score of 1.87 beat Longevity Health's score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the news media.

Company Overall Sentiment
Longevity Health Neutral
SkyAI, Inc. Warrant Very Positive

24.2% of Longevity Health shares are held by institutional investors. 29.0% of Longevity Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

SkyAI, Inc. Warrant beats Longevity Health on 5 of the 8 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to BIOLASE?

BIOLASE (NASDAQ:BIOL) and SkyAI, Inc. Warrant (NASDAQ:SKYAW) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

SkyAI, Inc. Warrant has lower revenue, but higher earnings than BIOLASE.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIOLASE$48.83M0.00-$20.63M-$14.94N/A
SkyAI, Inc. Warrant$396.90K0.54N/AN/AN/A

8.8% of BIOLASE shares are held by institutional investors. 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

SkyAI, Inc. Warrant has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. SkyAI, Inc. Warrant's return on equity of 0.00% beat BIOLASE's return on equity.

Company Net Margins Return on Equity Return on Assets
BIOLASE-41.65% -1,782.73% -55.31%
SkyAI, Inc. Warrant N/A N/A N/A

In the previous week, SkyAI, Inc. Warrant had 1 more articles in the media than BIOLASE. MarketBeat recorded 1 mentions for SkyAI, Inc. Warrant and 0 mentions for BIOLASE. SkyAI, Inc. Warrant's average media sentiment score of 1.87 beat BIOLASE's score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the news media.

Company Overall Sentiment
BIOLASE Neutral
SkyAI, Inc. Warrant Very Positive

Summary

SkyAI, Inc. Warrant beats BIOLASE on 5 of the 8 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to Profusa?

Profusa (NASDAQ:PFSA) and SkyAI, Inc. Warrant (NASDAQ:SKYAW) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

SkyAI, Inc. Warrant has higher revenue and earnings than Profusa.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Profusa$100K4.03-$35.82M-$169.72N/A
SkyAI, Inc. Warrant$396.90K0.54N/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profusa
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SkyAI, Inc. Warrant
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

9.8% of Profusa shares are owned by institutional investors. 0.8% of Profusa shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Profusa had 4 more articles in the media than SkyAI, Inc. Warrant. MarketBeat recorded 5 mentions for Profusa and 1 mentions for SkyAI, Inc. Warrant. SkyAI, Inc. Warrant's average media sentiment score of 1.87 beat Profusa's score of 0.38 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the news media.

Company Overall Sentiment
Profusa Neutral
SkyAI, Inc. Warrant Very Positive

Company Net Margins Return on Equity Return on Assets
ProfusaN/A N/A -1,348.07%
SkyAI, Inc. Warrant N/A N/A N/A

Summary

Profusa beats SkyAI, Inc. Warrant on 5 of the 8 factors compared between the two stocks.

Get SkyAI, Inc. Warrant News Delivered to You Automatically

Sign up to receive the latest news and ratings for SKYAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SKYAW vs. The Competition

Export
MetricSkyAI, Inc. WarrantMedical Instruments & Supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$216K$2.95B$7.09B$12.66B
Dividend YieldN/A1.91%2.68%8.00%
P/E RatioN/A17.2127.4224.53
Price / Sales0.54109.49528.3396.17
Price / CashN/A146.5448.4760.03
Price / BookN/A2.5710.886.38
Net IncomeN/A$99.80M$3.59B$331.87M
7 Day PerformanceN/A1.06%-0.26%0.37%
1 Month PerformanceN/A3.50%4.55%0.59%
1 Year PerformanceN/A-6.11%29.86%22.26%

SkyAI, Inc. Warrant Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SKYAW
SkyAI, Inc. Warrant
N/A$0.02
-8.2%		N/A+3.4%$216K$396.90KN/A3
SSKN
Strata Skin Sciences
N/A$0.13
flat		N/A-100.0%$771K$30.98MN/A120
DYNT
Dynatronics
N/AN/AN/AN/A$653K$33.60MN/A200
XAGE
Longevity Health
N/A$0.34
+30.4%		N/A-91.6%$604K$1.05MN/A14
BIOL
BIOLASE
N/AN/AN/AN/A$581K$48.83MN/A160

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SKYAW) was last updated on 7/12/2026 by MarketBeat.com Staff.
From Our Partners
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Buy the “unseen winner of the AI race” before July 22
Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Simple Options Trading For Beginners' book at no cost - normally $29.97. It ou...
Profits Run | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel